The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of fruquintinib plus trifluridine/tipiracil (TAS-102) as third-line treatment in patients with metastatic colorectal adenocarcinoma: Results from a single arm, phase 2, multicenter study.
 
Jianjun Peng
No Relationships to Disclose
 
Jianting Long
No Relationships to Disclose
 
Ling Huang
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Jianjun Xiao
No Relationships to Disclose
 
Jianhua Liu
No Relationships to Disclose
 
Haibo Zhang
No Relationships to Disclose
 
Derong Xie
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Chengyin Weng
No Relationships to Disclose
 
Zongcheng Zhang
No Relationships to Disclose
 
Xiaoshu Chai
No Relationships to Disclose